Medbox Retains DelMorgan & Co. as Financial Advisor to Explore Strategic Alternatives
WEST HOLLYWOOD, Calif., Nov. 7, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) , a leader in providing industry specific consulting services and patented systems to the medical and retail industries, announced today that it has retained DelMorgan & Co. , an internationally recognized investment banking firm, as its financial advisor to advise Medbox on its strategic alternatives, including potential acquisitions or divestitures, growth capital investments, joint ventures or other strategic alliances, and other initiatives to deliver shareholder value.
Dr. Bruce Bedrick, Medbox Chief Executive Officer, noted, "We are very excited about our engagement of DelMorgan & Co. Their experience and professionalism in capital raising and M&A will help us analyze Medbox's strategic options and pursue transactions that will benefit our company and our shareholders." Vincent Mehdizadeh, Medbox Chief Operating Officer, added, "We have so many opportunities for growth for our Medbox Dispensing System, and recent developments in the #$%$ space have led to an exponential increase in the number of inquiries and possibilities for the application of Medbox's systems, software and consulting services throughout North America and overseas. By working closely with DelMorgan, we can do a more rigorous evaluation of our options and position the Company for growth to the next level."